Evidence map›Paper›PMID 35352988›Full record

ArticleJournal of women's health (2002)2022

Association of Prepregnancy Substance Use and Substance Use Disorders with Pregnancy Timing and Intention.

Kelsey C Coy, Jean Y Ko, Steven J Ondersma, Kathryn Gilstad-Hayden, Lauren B Zapata, Grace Chang, Kimberly Yonkers

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of women's health (2002), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kelsey C CoyDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jean Y KoDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Steven J OndersmaDepartment of Psychiatry and Behavioral Neurosciences, Merrill Palmer Skillman Institute Wayne State University, Detroit, Michigan, USA.
Kathryn Gilstad-HaydenDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Lauren B ZapataDivision of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Grace ChangDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Kimberly YonkersDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Funding

PRENATAL SUBSTANCE USE SCREENING: VALIDATION AND COMPARISON OF PROMISING MEASURESR21DP006082 · DP · YALE UNIVERSITY · PI YONKERS, KIMBERLY A · 2015 to 2016
$1.2M
NCCDPHP CDC HHS R21 DP006082
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IntentionSubstance-Related DisordersFamily Planning ServicesFemaleHumansPregnancyPrenatal CarePrevalencepregnancy intentionpregnancy timingsubstance use disorders

Identifiers

PMID35352988
PMCPMC10970710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.